Results 101 to 110 of about 11,371 (259)

High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. [PDF]

, 2005
SETTING: Thyolo District Hospital, rural Malawi. OBJECTIVES: In a prevention of mother-to-child HIV transmission (PMTCT) programme, to determine: the acceptability of offering 'opt-out' voluntary counselling and HIV-testing (VCT); the progressive loss to
Brahmbhatt, Bulterys, Caballero-Gordo, Graham, Graham, Green, Guay, Isenalumbe, MOHP, MOHP, MOHP, MOHP, Newell, Nolan, NSO, Stringer, Sweat, Taha, Taha, UNAIDS/WHO, VCT group, Walraven, WHO, WHO/UNAIDS, World Health Organization (WHO), Zachariah, Zachariah   +26 more
core   +2 more sources

Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients [PDF]

The Journal of Clinical Endocrinology & Metabolism, 1998
Cabergoline is a new, long acting, dopamine agonist that is more effective and better tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine agonists still have a place in the medical management of acromegaly, cabergoline might be a useful treatment.
Abs, Roger, Verhelst, J., Maiter, Dominique, van Acker, K., Nobels, F., Coolens, J.-L., Mahler, Charles, Beckers, A.   +7 more
openaire   +5 more sources

Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 3, March 2025.
ABSTRACT Background Direct Healthcare Professional Communications (DHPCs) are an important risk minimisation measure. Their effect has been shown to be variable and has been measured using different outcomes and study populations. Depending on the content of the message, the optimal outcome to measure a direct effect of the DHPC can differ.
Esther de Vries, Petra Denig, Taco B. M. Monster, Peter G. M. Mol   +3 more
wiley   +1 more source

Clinical profile and early therapeutic response to cabergoline of patients with hyperprolactinemia in a cameroonian population

The Pan African Medical Journal, 2020
Hyperprolactinemia is responsible for 20 to 25% of consultations of secondary amenorrhea and 17% for female infertility. Dopamine agonists are the gold standard treatment of hyperprolactinemia.
Martine Claude Etoa Etoga, Eugène Sobngwi, Pelagie Ngoune, Emmanuella Doh, Francine Mendane Mekobe, Noel Mbango-Ekouta, Mesmin Dehayem, Pascal Foumane, Jean Claude Mbanya   +8 more
doaj   +1 more source

The effect of cabergoline on level of liver enzymes [PDF]

, 2011
زمینه و هدف: به علت اهمیت نقش کبد در ارتباط با متابولیسم داروهای شیمیایی و سنتز پروتئین های پلاسما و استفاده زیاد از داروی کابرگولین در درمان بیماری هیپرپرولاکتینمیا، پارکینسون و برخی اختلالات دیگر این مطالعه با هدف بررسی اثر داروی کابرگولین بر غلظت ...
Azarnoush, Jaleh., Mokhtari, Mokhtar., Shariatie, Mehrdad.   +2 more
core  

The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan

Cancer Science, Volume 116, Issue 3, Page 783-791, March 2025.
We conducted a population‐based case–control study from Taiwan, linking Health and Welfare Data Science Center data to the Taiwan Cancer Registry to evaluate the potential repurposing of anti‐parkinsonian drugs for pancreatic cancer treatment. The findings revealed a statistically significant association of the administration with specific anti ...
Hsuan‐Chia Yang, Wen‐Chi Chou, Phung‐Anh Nguyen, Nhi Thi Hong Nguyen, Nguyen Thi Phuong, Ching‐Huan Wang, Jason C. Hsu, Ming‐Chin Lin, Chih‐Wei Huang   +8 more
wiley   +1 more source

Contribution of Glutamatergic and GABAergic Mechanisms to the Plasticity‐Modulating Effects of Dopamine in the Human Motor Cortex

Human Brain Mapping, Volume 46, Issue 3, February 15, 2025.
Background: Dopamine modulates cortical excitability and plasticity by influencing glutamate and GABA receptor activity. This study investigates the impact of general dopaminergic activation and D1‐ and D2‐like receptor modulation on transcranial direct current stimulation (tDCS)‐induced plasticity in humans.Methods:• Pharmacological intervention: l ...
Elham Ghanavati, Mohammad Ali Salehinejad, Marie C. Beaupain, Lorena Melo, Amba Frese, Min‐Fang Kuo, Michael A. Nitsche   +6 more
wiley   +1 more source

The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors

Brain Pathology, Volume 35, Issue 1, January 2025.
Abstract The vast majority of pituitary neuroendocrine tumors (PitNETs) are benign and slow growing with a low relapse rate over many years after surgical resection. However, about 40% are locally invasive and may not be surgically cured, and about one percentage demonstrate an aggressive clinical behavior.
Olivera Casar‐Borota, Pia Burman, M. Beatriz Lopes   +2 more
wiley   +1 more source

Neuroendocrine tumours and pregnancy: Real‐world data from an European Neuroendocrine Tumour Centre of Excellence

Journal of Neuroendocrinology, Volume 37, Issue 1, January 2025.
Abstract Neuroendocrine neoplasms (NENs) arise from the diffuse endocrine system and have been considered to be rare. However, the incidence and prevalence of these tumours have increased in recent years, and they are being seen in younger patients including women in the reproductive age group.
Gowri M. Ratnayake, Kalyan Mansukhbhai Shekhda, Thomas Glover, Yasser Al‐Obudi, Aimee Hayes, Panagiotis Armonis, Dalvinder Mandair, Bernard Khoo, TuVinh Luong, Christos Toumpanakis, Ashley Grossman, Martyn Caplin   +11 more
wiley   +1 more source

Time‐dependent MR diffusion analysis of functioning and nonfunctioning pituitary adenomas/pituitary neuroendocrine tumors

Journal of Neuroimaging, Volume 35, Issue 1, January/February 2025.
Background and Purpose Differentiation between functioning and nonfunctioning pituitary adenomas/pituitary neuroendocrine tumors (PAs) is clinically relevant. The goal of this study was to determine the feasibility of using time‐dependent diffusion MRI (dMRI) for microstructural characterization of PAs.
Kiyohisa Kamimura, Tomohiro Tokuda, Junki Kamizono, Tsubasa Nakano, Tomohito Hasegawa, Masanori Nakajo, Fumitaka Ejima, Fumiko Kanzaki, Koji Takumi, Masatoyo Nakajo, Shingo Fujio, Ryosuke Hanaya, Akihide Tanimoto, Takashi Iwanaga, Hiroshi Imai, Thorsten Feiweier, Takashi Yoshiura   +16 more
wiley   +1 more source